TNDM(Tandem Diabetes Care, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $702.80M | $801.22M | $747.72M | $940.20M | $1.01B |
| 毛利润 | $376.21M | $412.99M | $367.69M | $489.57M | $546.01M |
| 营业利润 | $22.65M | −$92.85M | −$233.23M | −$99.13M | −$187.26M |
| 净利润 | $15.57M | −$94.59M | −$222.61M | −$96.03M | −$204.71M |
| 经营现金流 | $111.36M | $50.46M | −$31.81M | $24.23M | −$9.72M |
| 自由现金流 | $97.18M | $16.37M | −$58.61M | $4.99M | −$29.67M |
| 摊薄每股收益 | $0.24 | $-1.47 | $-3.43 | $-1.47 | $-3.04 |